Authors
No takes yet. Share an insight, caveat, or question.
Emerging biomarkers improve early detection of ovarian cancer, suggesting enhanced survival via targeted screening.
Cristina Vaida (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: